Sort by
Refine Your Search
-
to neoadjuvant treatment in rectal cancer patients and will also determine the relationship between complement and key immune cells in the tumour microenvironment to identify novel combination immunotherapy and
-
the tumour microenvironment to identify novel combination immunotherapy and neoadjuvant treatment approaches for those patients who are resistant to the current standard of care. Post Doctoral Researcher Level
-
-environment-climate public goods (AECPG). By combining insights from results-based, collective and spatially targeted schemes with novel financing and robust monitoring, REWARD seeks to build scalable models
-
are no longer practical. This project aims to automate anomaly detection (identifying missing, stuck, and suspicious data) at high temporal resolution (five-minute intervals) by combining Python-based rule-based
-
on predictive performance, the research will investigate methods to balance model accuracy and computational complexity, enabling the development of more sustainable modelling approaches. The project combines
-
and electrical measurements, combining groundwater flow models with Electrical Impedance Tomography to improve the characterisation of aquifers. The researcher will be based in the Department
-
. The position will combine systems physiology, host–microbe biology and multi-modal phenotyping with metabolomic, immune, endocrine and behavioural approaches. Working closely with researchers in experimental
-
effectively about scientific and technological innovation when they are given explicit information about the higher-order structure of the underlying data. The project will combine topological data analysis
-
stress, systemic inflammation and circadian disruption reshape communication across these systems. The position will combine systems physiology, host–microbe biology and multi-modal phenotyping with
-
collaboration with clinical, commercial and regulatory partners. The project combines mechanistic microbiome science with human clinical research and commercialisation activities to advance a novel postbiotic